Risk of subsequent dementia diagnoses does not vary by types of adjuvant chemotherapy in older women with breast cancer.

Raji MA, Tamborello LP, Kuo YF, Ju H, Freeman JL, Zhang DD, Giordano SH, Goodwin JS. Risk of subsequent dementia diagnoses does not vary by types of adjuvant chemotherapy in older women with breast cancer. Med Oncol. 2009 Dec; 26(4):452-9.

View in: PubMed

subject areas

Aged
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
Chemotherapy, Adjuvant
Dementia
Female
Humans
Risk Factors
SEER Program
Survival Rate
Treatment Outcome

authors with profiles

J Shawn Goodwin

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support